The purpose of this research study is to determine if semaglutide, when compared to placebo,
is safe and may reduce alcohol drinking in individuals who endorse symptoms consistent with
alcohol use disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Oklahoma State University Center for Health Sciences